Abstract
Infections caused by antibiotic-resistant bacteria are among the leading causes of death for people of all ages, revealed by a global study on antimicrobial resistance (AMR). Peptides and peptidomimetics are re-emerging as candidates in the development of therapeutic strategies due to their specificity and low toxicity. In this context, a strategy for the design and optimization of pepti…